TY - JOUR
T1 - Gut microbiota-dependent increase in phenylacetic acid induces endothelial cell senescence during aging
AU - Saeedi Saravi, Seyed Soheil
AU - Pugin, Benoit
AU - Constancias, Florentin
AU - Shabanian, Khatereh
AU - Spalinger, Marianne
AU - Thomas, Aurélien
AU - Le Gludic, Sylvain
AU - Shabanian, Taraneh
AU - Karsai, Gergely
AU - Colucci, Manuel
AU - Menni, Cristina
AU - Attaye, Ilias
AU - Zhang, Xinyuan
AU - Allemann, Meret Sarah
AU - Lee, Pratintip
AU - Visconti, Alessia
AU - Falchi, Mario
AU - Alimonti, Andrea
AU - Ruschitzka, Frank
AU - Paneni, Francesco
AU - Beer, Jürg H
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/6
Y1 - 2025/6
N2 - Endothelial cell senescence is a key driver of cardiovascular aging, yet little is known about the mechanisms by which it is induced in vivo. Here we show that the gut bacterial metabolite phenylacetic acid (PAA) and its byproduct, phenylacetylglutamine (PAGln), are elevated in aged humans and mice. Metagenomic analyses reveal an age-related increase in PAA-producing microbial pathways, positively linked to the bacterium Clostridium sp. ASF356 (Clos). We demonstrate that colonization of young mice with Clos increases blood PAA levels and induces endothelial senescence and angiogenic incompetence. Mechanistically, we find that PAA triggers senescence through mitochondrial H2O2 production, exacerbating the senescence-associated secretory phenotype. By contrast, we demonstrate that fecal acetate levels are reduced with age, compromising its function as a Sirt1-dependent senomorphic, regulating proinflammatory secretion and redox homeostasis. These findings define PAA as a mediator of gut-vascular crosstalk in aging and identify sodium acetate as a potential microbiome-based senotherapy to promote healthy aging.
AB - Endothelial cell senescence is a key driver of cardiovascular aging, yet little is known about the mechanisms by which it is induced in vivo. Here we show that the gut bacterial metabolite phenylacetic acid (PAA) and its byproduct, phenylacetylglutamine (PAGln), are elevated in aged humans and mice. Metagenomic analyses reveal an age-related increase in PAA-producing microbial pathways, positively linked to the bacterium Clostridium sp. ASF356 (Clos). We demonstrate that colonization of young mice with Clos increases blood PAA levels and induces endothelial senescence and angiogenic incompetence. Mechanistically, we find that PAA triggers senescence through mitochondrial H2O2 production, exacerbating the senescence-associated secretory phenotype. By contrast, we demonstrate that fecal acetate levels are reduced with age, compromising its function as a Sirt1-dependent senomorphic, regulating proinflammatory secretion and redox homeostasis. These findings define PAA as a mediator of gut-vascular crosstalk in aging and identify sodium acetate as a potential microbiome-based senotherapy to promote healthy aging.
KW - Gastrointestinal Microbiome/physiology
KW - Animals
KW - Phenylacetates/metabolism
KW - Cellular Senescence/physiology
KW - Aging/metabolism
KW - Humans
KW - Mice
KW - Endothelial Cells/metabolism
KW - Male
KW - Clostridium/metabolism
KW - Mice, Inbred C57BL
KW - Hydrogen Peroxide/metabolism
KW - Female
KW - Glutamine/analogs & derivatives
KW - Feces/microbiology
KW - Aged
KW - Mitochondria/metabolism
KW - Sirtuin 1/metabolism
UR - http://www.scopus.com/inward/record.url?scp=105004770860&partnerID=8YFLogxK
U2 - 10.1038/s43587-025-00864-8
DO - 10.1038/s43587-025-00864-8
M3 - Article
C2 - 40355758
SN - 2662-8465
VL - 5
SP - 1025
EP - 1045
JO - Nature Aging
JF - Nature Aging
IS - 6
ER -